Edwards Lifesciences Corp (NYSE:EW)

148.13
Delayed Data
As of Jul 13
 +0.96 / +0.65%
Today’s Change
100.20
Today|||52-Week Range
155.22
+31.43%
Year-to-Date
Here's Why You Should Add Edwards Lifesciences (EW) Now
Jul 13 / Zacks.com - Paid Partner Content
David Rolfe Is Taking GuruFocus Reader Questions
Jul 09 / GuruFocus News - Paid Partner Content
David Rolfe Is Taking Investing Questions From GuruFocus Users
Jul 09 / GuruFocus News - Paid Partner Content
Bear of the Day: Barrick Gold (ABX)
Jul 03 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close147.17
Today’s open147.20
Day’s range146.93 - 148.78
Volume970,700
Average volume (3 months)1,331,723
Market cap$29.1B
Data as of 4:01pm ET, 07/13/2018

Growth & Valuation

Earnings growth (last year)+3.45%
Earnings growth (this year)+21.76%
Earnings growth (next 5 years)+18.00%
Revenue growth (last year)+15.91%
P/E ratio57.0
Price/Sales7.08
Price/Book9.79

Competitors

 Today’s
change
Today’s
% change
SNNSmith & Nephew PLC-0.08-0.22%
ISRGIntuitive Surgical-0.66-0.13%
STESTERIS plc+0.21+0.19%
HRCHill-Rom Holdings In...+0.83+0.92%
Data as of 4:02pm ET, 07/13/2018

Financials

Next reporting dateJuly 27, 2018
EPS forecast (this quarter)$1.13
Annual revenue (last year)$3.4B
Annual profit (last year)$583.6M
Net profit margin16.99%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Michael A. Mussallem
Chief Financial Officer &
Vice President
Scott B. Ullem
Corporate headquarters
Irvine, California

Forecasts